Načítá se...

SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.

Candida krusei is increasingly recognized as an opportunistic pathogen in immunocompromised patients and is inherently resistant to fluconazole. We tested the in vivo efficacy of SCH 51048, an investigational antifungal triazole, in experimental hematogenous murine infection caused by two C. krusei...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Karyotakis, N C, Dignani, M C, Anaissie, E J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1995
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC162625/
https://ncbi.nlm.nih.gov/pubmed/7793892
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!